Welcome to MolDiag-PaCa
1) Brandt, R., Grützmann, R., Bauer, A., Jesnowski, R., Ringel, J., Löhr, M., Pilarsky, C. & Hoheisel, J.D. (2004). DNA-microarray analysis of pancreatic malignancies. Pancreatology 368, in press.

2) Esposito, I., Bauer, A., Hoheisel, J.D., Kleeff, J., Friess, H., Büchler, M.W., Bergmann, F., Rieker, R.J., Otto, H.F., Klöppel, G., & Penzel, R. (2004). Microcystic tubulopapillary carcinoma of the pancreas: a new tumor entity. Virchows Arch. 444, 447-453.

3) Beier, M., Stephan, A. & Hoheisel, J.D. (2001). Synthesis of photolabile 5'-O-phosphoramidites for the production of microarrays of inversely oriented oligonucleotides. Hel. Chim. Acta 84, 2089-2095; International Patent PCT/DE00/001148.

4) Fellenberg, K., Hauser, N.C., Brors, B., Hoheisel, J.D. & Vingron, M. (2002). Microarray data warehouse allowing for the statistical analysis of experiment annotations. Bioinformatics 18, 423-433; European Patent Appl. 01123732.8.

5) Kusnezow, W., Jacob, A., Walijew, A., Diehl, F. & Hoheisel, J.D. (2003). Antibody microarrays: an evaluation of production parameters. Proteomics 3, 254-264.

1) Dowen SE*, Crnogorac-Jurcevic T*, Gangeswaran R, Hansen M, Eloranta JJ, Bhakta V, Brentnall T, Lüttges J, Klöppel G, Lemoine NR. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer (2005) Am J Pathol 166(1):81-92.

2) Missiaglia E, Blaveri E, Terris B, Wang Y, Costello E, Neoptolemos JP, Crnogorac-Jurcevic T, Lemoine NR. (2004) Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer 112: 100-112.

3) Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, Gangeswaran R, Jones M, Terris B, Costello E, Neoptolemos JP, Rogers S, Campbell C, Lemoine NR. (2003) Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 201: 63-74.

4) Crnogorac-Jurcevic T, Efthimiou E, Neilsen T, Loader J, Terris B, Stamp GWH, Keating S, Baron A, Scarpa A, Lemoine NR. (2002) Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 21: 4587-4594.

5) Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E, Terris B, Baron A, Jones M, Tyson K, Bassi C, Scarpa A, Lemoine NR. (2001) Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 20: 7437-7446.

1) Vimalachandran D., Greenhalf W., Watson R., Thompson C., Prime W., Campbell F., Dodson A., Lemoine NR. Crnogorac-Jurcevic T., Neoptolemos JP., Costello, E. Nuclear S100A6 is associated with poor survival in pancreatic cancer Cancer Research 2005; 65:3218-25.

2) Yan L, McFaul C, Howes N, Leslie J, Lancaster G, Wong T, Evans J, Gilmore I, Smart H, Lombard M, Neoptolemos J, Greenhalf W. Molecular Analysis To Detect Pancreatic Ductal Adenocarcinoma In High Risk Groups. Gastroenterology 2005;128:2124-30.

3) Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Büchler MW for the members of the European Study Group for Pancreatic Cancer (ESPAC). The final results of the European Study Group for Pancreatic Cancer randomized controlled trial of adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer. N Engl J Med 2004; 350:1200-10.

4) Hahn SA, Greenhalf B, Ellis I, Sina-Frey M, Rieder H, Korte B, Gerdes B, Kress R, Ziegler A, Raeburn JA, Campra D, Grutzmann R, Rehder H, Rothmund M, Schmiegel W, Neoptolemos JP, Bartsch DK. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 2003;95:214-21.

5) Shekouh AR, Thompson CC, Prime W, Campbell F, Hamlett J, Herrington CS, Lemoine NR, Tatjana Crnogorac-Jurcevic, Buechler MW, Friess H, Neoptolemos JP, Pennington SR, Costello E. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 2003; 3:1988.

1) Gress TM, Müller-Pillasch F, Geng M, Zimmerhackl F, Zehetner G, Friess H, Büchler M, Adler G, Lehrach H. A pancreatic cancer-specific expression profile. Oncogene 13:1819-1830 (1996).

2) Weber CK, Sommer G, Michl P, Fensterer H, Weimer M, Gansauge F, Leder G, Adler G, Gress TM. Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology 121:657-667 (2001).

3) Michl P, Buchholz M, Rolke M, Loehr M, Kunsch S, Menke A, McClane B, Tsukita S, Iwamura T, Leder G, Adler G, Gress TM. Claudin-4: A new target for therapy of solid tumours using clostridium perfringens enterotoxin. Gastroenterology 121: 678-684 (2001).

4) Wagner M., Kunsch S, Duerschmied D, Beil M, Adler G, Mueller F, Gress TM. Transgenic overexpression of the oncofetal RNA binding protein KOC leads to remodelling of the exocrine pancreas. Gastroenterology, 124:1901-1914 (2003).

5) Mueller F, Lacher U, Ruhland C, Bommer M, Stagge V, Adler G, Seufferlein T*, GressTM* KOC is a novel molecular indicator of malignancy. Br J Cancer 88: 699-701 (2003).Joint “senior authorship” of Gress TM and Seufferlein T.

6) Buchholz M., Kestler H., Bauer A., Böck W., Rau. B., Leder G., Kratzer W., Bommer M, Adler G., Hoheisel J., Gress TM. Specialized DNA arrays for the differentiation of pancreatic tumours: A solution for a common diagnostic dilemma. Clin.Cancer Res. In press.

7) Buchholz M., Braun M., Heidenblut A., Kestler H., Klöppel G., Schmiegel, W., Hahn SA.* , Lüttges J.*, Gress TM.* for the German PDAC Net of the Deutsche Krebshilfe. Transcriptome Analysis of Microdissected Pancreatic Intraepithelial Neoplastic Lesions. (* shared senior authorship), Oncogene 24, 6626-6636 (2005)